$1.12
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Country

US

CEO

Mr. Paul Danner

IPO date

2022

Employees

5

ISIN

US82003F3091

Key stats

Open

$1.11

Volume

79.40K

Market cap

$49.09M

Prev. close

$1.15

Impl / hst vl

-

Open interest

$0.00

$1.11

Day’s Range

$1.25

$0.91

52W Range

$1.83

Valuation

50
Valuation score
Fairly Valued
P/E
-
P/S
-
P/B
-
Current ratio
8.28
Debt / Equity
-0.07
ROE
-166.42%
Gross margin
93.91%
Income growth
-
FCF growth
-

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy

Earnings

Q4 ‘22 revenue
$0.00
Q4 ‘22 net income
$2.58M
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply